SCHEMBL6865122

SCHEMBL6865122

COc1cc(Cl)nc2[nH]nc(C3CCC3)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
CDK2 P24941 2/20 0.34
CDK9 P50750 2/20 0.34
CDK5 Q00535 2/20 0.34
CCNT1 O60563 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK5R1 Q15078 1/20 0.34
JUND P17535 1/20 0.33
FOSB P53539 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
HPGD P15428 3/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12019130 0.85 CCNT1 (0.34) HTR2ACDK2CDK9CDK5CCNT1
SCHEMBL1662955 0.76 FYN (0.40) HTR2AHTR2CPDE3BPDE3APDGFRB
SCHEMBL1662366 0.75 CCNT1 (0.39) HTR2ACDK2CDK9CDK5CCNT1
SCHEMBL30682140 0.74 HPGD (0.35) HPGDKDM4EALDH1A1HSD17B10NPC1
SCHEMBL28412458 0.74 HPGD (0.35) HPGDKDM4EALDH1A1HSD17B10NPC1
SCHEMBL30592291 0.69 CCNT1 (0.41) HTR2ACDK2CDK9CDK5CCNT1
SCHEMBL18692732 0.66 CFTR (0.42)
SCHEMBL17837929 0.65 FYN (0.45) HTR2CCDK2CDK9CCNT1
SCHEMBL18705507 0.65 PDE5A (0.33) PDE3BPDE3ASMN1; SMN2
SCHEMBL18705431 0.65 SMN1; SMN2 (0.40) HPGDKDM4EALDH1A1HSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-08-30 US disclosed
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-08-30 US disclosed
WO-2011049722-A1 PYRAZOLO [3,4-b] PYRIDIN-4-ONE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220624-A1 PYRAZOLO [3,4-B] PYRIDIN-4-ONE KINASE INHIBITORS CDK1, CDK5, TTBK1 HTR2A 3793/4885HTR2C 2666/4885CDK2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.